Vnitřní lékařství 5/2020

KAZUISTIKA Transplantace jater jako potenciální kurativní metoda těžké hemofilie A: popis případu a literární přehled | E47  / Vnitř Lék 2020; 66(5): e43–e47 /  VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz LITERATURA 1. Matýšková M, Penka M. Hemofilie. Vnitř Lék 1991; 37: 397–403. 2. Maier KP. Hepatitis‑Hepatitisfolgen. 6. Aufl. Bern: Verlag Hans Huber 2010, 457 s. 3. Chorba TL, Holman RC, Clarke MJ, et al. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol 2001; 66: 229–240. 4. Lewis JH, Bontempo FA, Spero JA, et al. Liver transplantation in a hemophiliac. N Engl J Med 1985; 312: 1189–1190. 5. Norman JC, Lambilliotte JP, Kojima Y, et al. Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia. Science 1967; 158: 1060–1061. 6. Webster WP, Zukoski CF, Hutchin P, et al. Plasma factor VIII synthesis and control as reve‑ aled by canine organ transplantation. Am J Physiol 1971; 220: 1147–1154. 7. Stel HV, van der Kwast TH, Veerman EC. Detection of factor VIII/coagulant antigen in hu‑ man liver tissue. Nature 1983; 303: 530–532. 8. Webster WP, Mandel SR, Reddick RL, et al. Orthotopic liver transplantation in canine he‑ mophilia B. Am J Physiol 1974; 226: 496–500. 9. Kleeberger W, Rothamel T, Glockner S, et al. High frequency of epithelial chimerism in liver transplants demonstrated bymicrodissection and STR‑analysis. Hepatology 2002; 35: 110–116. 10. Zanolini D, Merlin S, Feola M et, al. Extrahepatic sources of factor VIII potentially con‑ tribute to the coagulation cascade correcting the bleeding phenotype of mice with he‑ mophilia A. Haematologica 2015; 100: 881–892. 11. Groth CG, Ringdén O. Transplantation in relation to the treatment of inherited disea‑ se. XXXXXXXXX XXXX; XXX: XXX–XXX. 12. Gupta E, Finn L, Johns G, et al. Correction of factor XI deficiency by liver transplantati‑ on. Blood Coagul Fibrinolysis 2015; 26: 961–963. 13. Gallastegui N, Kimble EL, Harrington TJ. Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation. Haemophilia 2016; 22: e36–e79. 14. Alonso Madrigal C, Dobón Rebollo M, Laredo de la Torre V, et al. Trasplante hepático en hemofilia A y enfermedad de von Willebrand tipo 3. Manejo perioperatorio y evoluci‑ ón postrasplante. Rev Esp Enferm Dig 2018; 110: 522–526. 15. Suzuki Y, Kakisaka K, Matsumoto T, et al. Orthotopic liver transplantation for haemo‑ philia A may not always lead to a phenotypic cure of haemophilia A: A case report. Hae‑ mophilia 2018; 24: e420-e422. 16. Murthy V, Murray D, Hebballi S, et al. Outcome of liver transplantation in pati‑ ents with hereditary bleeding disorders: a single centre UK experience. Haemophi‑ lia 2016; 22: e139-e144. 17. Khakhar AK, Chan NG, Allan DS, et al. Catastrophic microangiopathy induced by high­ ‑titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis. Ha‑ emophilia 2005; 11: 623–628. 18. Srivastava A, Brewer AK, Mauser‑Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1-e47. 19. Merlen C, Zourikian N, Bonnefoy A, et al. Effect of ABO blood group on haemostatic parameters in severe haemophilia A patients performing acute moderate‑intensity exer‑ cise. Blood Coagul Fibrinolysis 2018; 29: 626–635. 20. Shapiro AD, Korth‑Bradley J, Poon MC. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia 2005; 11: 571–582. 21. Björkman S, Folkesson A, Berntorp E. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting. Haemophilia 2007; 13: 2–8. 22. Hazendonka HCAM, van Moorta I, Mathô RAA, et al. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play? Blood Rev 2018; 32: 265–271. 23. Togashi J, Akamatsu N, Tanaka T, et al. Living donor liver transplantation for hemophilia with special reference to the management of perioperative clotting factor replacement. Liver Transplant 2016; 22: 366–370. 24. Ragni MV, Devera ME, Roland ME, et al. Liver transplant outcomes in HIV+ haemophi‑ lic men. Haemophilia 2013; 19: 134–140. 25. Yokoyama S, Bartlett A, Dar FS, et al. Outcome of liver transplantation for haemophi‑ lia. HPB (Oxford) 2011; 13: 40–45. 26. Goldmann G, Zeitler H, Marquardt N, et al. Long‑term outcome of liver transplantati‑ on in HCV/HIV coinfected haemophilia patients. A single centre study of 10 patients. Ha‑ mostaseologie 2015; 35: 175–180. 27. Park YK, Kim HC, Kim BW, et al. Auxiliary partial orthotopic liver transplantation as a tre‑ atment for hemophilia a: a case report. Transplant Proc 2015; 47: 161–164. 28. Charvát J, Vychodil P, Adamec M, et al. Vyléčení těžké formy hemofilie A transplantací jater – kazuistika. Trombóza a hemostáza. Hradec Králové: HK Credit 2007, 114 s. Víte, že listovačky časopisu Klinická farmakologie a farmacie jsou volně dostupné on-line? Mohou být přínosné i pro vás… V posledních číslech najdete tato hlavní témata: Farmakoterapie v zubním lékařství (1/2020) Farmakoterapie v těhotenství a při kojení (4/2019) Nežádoucí účinky léčiv (3/2019) ... a mnoho článků z jiných oblastí medicíny a farmacie www. klinickafarmakologie.cz